Liberia will soon receive doses of an experimental Ebola drug and give it to two sick doctors, making them the first Africans to receive some of the scarce treatment in a spiralling outbreak.
The US government has put Liberian officials in touch with the California-based maker of ZMapp, Mapp Biopharmaceutical. The company said that in responding to a request from an unidentified West African country, it had run out of its supply of the treatment.
The news comes as anger is growing over the fact that the only people to receive the experimental treatment so far have been Westerners: two Americans and a Spaniard, all of whom were evacuated to their home countries from Liberia.
As it reaches seven months since the Ebola outbreak started we take a look at the timeline of events leading up to the spread of the virus.
More than 100 British personnel are arriving in Sierra Leone to combat the Ebola outbreak in West Africa. Here's what else the UK is doing.
A man has been filmed helping an Ebola patient onto a plane without wearing any protective equipment.